Vanguard Group Inc Cue Biopharma, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,039,322 shares of CUE stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,039,322
Previous 3,187,346 4.64%
Holding current value
$1.91 Million
Previous $2.17 Million 1.85%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$0.67 - $0.9 $99,176 - $133,221
-148,024 Reduced 4.64%
3,039,322 $2.13 Million
Q2 2025

Aug 11, 2025
BUY
$0.58 - $0.86 $505,460 - $749,476
871,484 Added 37.63%
3,187,346 $2.17 Million
Q1 2025

May 09, 2025
BUY
$0.91 - $1.75 $236,314 - $454,450
259,686 Added 12.63%
2,315,862 $2.11 Million
Q4 2024

Feb 11, 2025
BUY
$0.71 - $1.88 $17,576 - $46,539
24,755 Added 1.22%
2,056,176 $2.12 Million
Q2 2024

Aug 13, 2024
SELL
$1.24 - $2.18 $312,406 - $549,231
-251,941 Reduced 11.03%
2,031,421 $2.52 Million
Q1 2024

May 10, 2024
BUY
$1.77 - $3.09 $266,308 - $464,912
150,457 Added 7.05%
2,283,362 $4.32 Million
Q4 2023

Feb 14, 2024
BUY
$1.72 - $3.1 $13,758 - $24,796
7,999 Added 0.38%
2,132,905 $5.63 Million
Q3 2023

Nov 14, 2023
BUY
$2.23 - $4.69 $170,331 - $358,231
76,382 Added 3.73%
2,124,906 $4.89 Million
Q2 2023

Aug 14, 2023
BUY
$3.11 - $4.91 $1.23 Million - $1.94 Million
394,928 Added 23.88%
2,048,524 $7.48 Million
Q1 2023

May 15, 2023
BUY
$2.41 - $3.74 $300,445 - $466,250
124,666 Added 8.15%
1,653,596 $5.9 Million
Q4 2022

Feb 10, 2023
BUY
$2.39 - $3.95 $15,800 - $26,113
6,611 Added 0.43%
1,528,930 $4.36 Million
Q2 2022

Aug 12, 2022
SELL
$2.49 - $5.92 $327,230 - $777,994
-131,418 Reduced 7.95%
1,522,319 $3.79 Million
Q1 2022

May 13, 2022
BUY
$4.41 - $12.28 $451,685 - $1.26 Million
102,423 Added 6.6%
1,653,737 $8.07 Million
Q4 2021

Feb 14, 2022
SELL
$10.86 - $17.85 $243,329 - $399,947
-22,406 Reduced 1.42%
1,551,314 $17.5 Million
Q3 2021

Nov 12, 2021
BUY
$10.06 - $15.3 $160,980 - $244,830
16,002 Added 1.03%
1,573,720 $22.9 Million
Q2 2021

Aug 13, 2021
BUY
$10.9 - $14.53 $17 Million - $22.6 Million
1,557,718 New
1,557,718 $18.1 Million

Others Institutions Holding CUE

# of Institutions
53
Shares Held
18.4M
Call Options Held
0
Put Options Held
0
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $22.3M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email